Clinical Genomics Pty Ltd and co-plaintiffs filed Clinical Genomics Pty Ltd et al. v. Grail, Inc., No. 1:26-cv-01147 (D. Del.), on September 11, 2026. Trade press coverage on September 14 reports a patent suit aimed at Galleri multi-cancer early detection testing.
Patents reported in public coverage
Public reporting identifies U.S. Patents 10,590,468 and 10,941,449, described as DNA-methylation and related diagnostics patents tied to Galleri. This page will be updated when the complaint becomes available.
What it means in plain terms
This is a biotech and diagnostics fight over multi-cancer blood testing, not a handset campaign. Delaware is a familiar forum for life-sciences patent cases.
What to watch next
Watch for Grail's answer, any early section 101 or validity motions, and parallel FDA or commercial developments around Galleri.